06-12-2009: Agilent Technologies Inc. announced researchers are developing new tools for rapidly characterizing biological pathogens that could give rise to potentially deadly pandemics such as Influenza A (H1N1). This is part of a joint effort by national laboratory-, university- and private-sector institutions.
The first tool, an automated genotyping system, is a joint effort between Los Alamos National Laboratory, the University of California at Los Angeles (UCLA) School of Public Health and Agilent. This system will be utilized in the Global Bio Lab at UCLA and will use high-throughput technology for automated global-public-health surveillance.
The automated genotyping system, built to specification by Agilent, was delivered to Los Alamos in late May for verification of design and capability testing. The $1.7 million BioCel Automation System was designed in collaboration by Los Alamos and UCLA researchers, and professionals at Agilent’s Automation Solutions division, previously known as Velocity11. The system will be able to automatically determine the genetic sequence of viruses such as influenza hundreds of times faster than any other method available today.
According to the company public-health officials will be able to rapidly and reliably determine the strain of a virus, allowing more time for mitigation or containment strategies to be employed if necessary by using this system and future high-throughput tools in pandemic response mode. Moreover, these BioCel systems will be useful in research mode for monitoring animal populations for the emergence of new and potentially deadly pathogens before the pathogens are able to infect humans. The UCLA Global Bio Lab will become part of the High Throughput Laboratory Network (HTLN). When built out, the network will provide an international and interconnected capacity that enables uniformity in testing methods - reducing the potential for errors or confusion arising from variable testing methodologies currently used.
Scientists have captured the first images of electrons that appear to take on extraordinary mass under certain extreme conditions, thus solving a 25-year mystery about how electrons behave in metals. The discovery could help with the design of new materials for high-temperature superconduct ... more
Agilent Technologies Inc. announced researchers are developing new tools for rapidly characterizing biological pathogens that could give rise to potentially deadly pandemics such as Influenza A (H1N1). This is part of a joint effort by national laboratory-, university- and private-sector in ... more
An engineered metamaterial proved it can function as a state-of-the-art device in the complex terahertz range of the electromagnetic spectrum, setting a standard of performance for modulating tiny waves of radiation, according to a team of researchers from Boston College, the Los Alamos and ... more
In the development of future molecular devices, new display technologies, and "artificial muscles" in nanoelectromechanical devices, functional molecules are likely to play a primary role.
Rotaxanes, one family of such molecules, are tiny, mechanically interlocked structures that consist o ... more
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. These cells, known as circulating tumor cells, or CTCs, can provide critical information for ex ... more
Flasks, beakers and hot plates may soon be a thing of the past in chemistry labs. Instead of handling a few experiments on a bench top, scientists may simply pop a microchip into a computer and instantly run thousands of chemical reactions, with results - literally shrinking the lab down to ... more